With 37 days left for NEET UG 2025, students must focus on Chemistry. Understanding the syllabus, practicing reactions, and ...

Primary care doctors concerned about telehealth GLP-1 boom: survey The first GLP-1s secured approval as diabetes therapies in 2014, but uptake was slow given that they required daily injections ...

In just a few years, GLP-1s have made quite the name for themselves. Originally prescribed to treat diabetes, these meds really entered the zeitgeist for their notable weight loss side effects.

A review of randomized clinical trials found 33 occurrences of suicide-related behaviors with GLP-1s vs 27 for placebo. Data showed no outcome differences based on diabetes status or type of GLP-1 ...

The use of GLP-1s in the perioperative period surrounding major surgeries, such as total joint arthroplasties, is a growing source of concern among orthopedic surgeons. A study presented at the 2025 ...

Researchers pointed to GLP-1s as a potential contributing factor, alongside pandemic-related shifts in behaviors. And while these medications may be helping address the nation’s obesity epidemic ...

It’s estimated about 9 per cent of Americans are on the new breed of weight loss drugs known as GLP-1s. While we don’t yet know how many Australians are taking the jab, we’re certainly ...

Now, some say we may have already found it. A fast-growing body of research signals potential health benefits of GLP-1s, the class of diabetes and weight-loss drugs known by names like Ozempic ...